You are here

Imfinzi

AstraZeneca reports positive results from endometrial cancer therapy trial

AstraZeneca reports positive results from endometrial cancer therapy trial

Clinical Trials Arena

endometrial cancer

clinical trials

Flag link:

AstraZeneca's drug combo shows positive results in late-stage cancer trial

AstraZeneca's drug combo shows positive results in late-stage cancer trial

Reuters

endometrial cancer

Flag link:

AACR: AstraZeneca offers first look at Imfinzi's resectable lung cancer showing, fueling a key debate

AACR: AstraZeneca offers first look at Imfinzi's resectable lung cancer showing, fueling a key debate

Fierce Pharma

non-small cell lung cancer

Flag link:

AstraZeneca's Lynparza-Imfinzi combo clears PhIII trial in ovarian cancer

AstraZeneca's Lynparza-Imfinzi combo clears PhIII trial in ovarian cancer

Endpoints

clinical trials

Flag link:

AstraZeneca says cancer drug Imfinzi improves survival chances in late-stage trial

AstraZeneca says cancer drug Imfinzi improves survival chances in late-stage trial

Reuters

Flag link:

Despite Imfinzi fail in lung cancer trial, AZ 'encouraged' by one result: exec

Despite Imfinzi fail in lung cancer trial, AZ 'encouraged' by one result: exec

Fierce Pharma

non-small cell lung cancer

Flag link:

AstraZeneca: FDA Approves Imfinzi Plus Chemotherapy To Treat Biliary Tract Cancer

AstraZeneca: FDA Approves Imfinzi Plus Chemotherapy To Treat Biliary Tract Cancer

NASDAQ

biliary tract cancer

Flag link:

AstraZeneca, chasing immunotherapy rivals, claims study success in early lung cancer

AstraZeneca, chasing immunotherapy rivals, claims study success in early lung cancer

BioPharma Dive

clinical trials

non-small cell lung cancer

Flag link:

Here's What AstraZeneca's Recent FDA News Means for Shareholders

Here's What AstraZeneca's Recent FDA News Means for Shareholders

Motley Fool

Flag link:

AZ eyes Q3 FDA decision for Imfinzi in biliary tract cancer

AZ eyes Q3 FDA decision for Imfinzi in biliary tract cancer

Pharmaforum

biliary tract cancer

priority review

Flag link:

AstraZeneca faces $278M Imfinzi patent infringement lawsuit from co-developer Ono

AstraZeneca faces $278M Imfinzi patent infringement lawsuit from co-developer Ono

Fierce Pharma

Ono Pharmaceutical

Flag link:

AZ’s Imfinzi is first immunotherapy to raise survival in biliary tract cancer

AZ’s Imfinzi is first immunotherapy to raise survival in biliary tract cancer

Pharmaforum

biliary tract cancer

clinical trials

Flag link:

AstraZeneca: Imfinzi Plus Tremelimumab Improves OS In Phase III Trial In Liver Cancer

AstraZeneca: Imfinzi Plus Tremelimumab Improves OS In Phase III Trial In Liver Cancer

NASDAQ

clinical trials

Flag link:

ESMO 2021 – Astra coasts towards a new lung cancer combo

ESMO 2021 – Astra coasts towards a new lung cancer combo

EP Vantage

non-small cell lung cancer

Flag link:

AstraZeneca touts Imfinzi immunotherapy combos for lung cancer in push to drive PD-L1 drug uptake

AstraZeneca touts Imfinzi immunotherapy combos for lung cancer in push to drive PD-L1 drug uptake

Endpoints

Flag link:

AstraZeneca earns another approval in jam-packed Chinese PD-(L)1 market, this time in late-stage lung cancer

AstraZeneca earns another approval in jam-packed Chinese PD-(L)1 market, this time in late-stage lung cancer

Endpoints

Flag link:

#ASCO21: AstraZeneca's PD-1 Imfinzi tacks on 5-year survival data in NSCLC, which it's calling 'unprecedented'

#ASCO21: AstraZeneca's PD-1 Imfinzi tacks on 5-year survival data in NSCLC, which it's calling 'unprecedented'

Endpoints

non-small cell lung cancer

Flag link:

Despite Imfinzi, US accelerated approvals surge

Despite Imfinzi, US accelerated approvals surge

EP Vantage

accelerated approvals

Flag link:

AZ withdraws Imfinzi in US bladder cancer use after trial failure

AZ withdraws Imfinzi in US bladder cancer use after trial failure

Pharmaforum

metastatic bladder cancer

clinical trials

Flag link:

AstraZeneca's Imfinzi Fails To Prolong Survival In Late-Stage Head And Neck Cancer Study

AstraZeneca's Imfinzi Fails To Prolong Survival In Late-Stage Head And Neck Cancer Study

Benzinga

head and neck cancer

clinical trials

Flag link:

Pages